NCT06930508 Bringing Medicines for HIV Prevention to a Family Planning Clinic
| NCT ID | NCT06930508 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Women and Infants Hospital of Rhode Island |
| Condition | HIV |
| Study Type | INTERVENTIONAL |
| Enrollment | 83 participants |
| Start Date | 2026-05-28 |
| Primary Completion | 2026-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 83 participants in total. It began in 2026-05-28 with a primary completion date of 2026-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to understand what patients and physicians think about providing medications to prevent HIV transmission to patients in a family planning clinic. These medications are known as pre-exposure prophylaxis, or PrEP. The main questions to answer are: 1. Do patients find it acceptable to be asked about, and offered, PrEP during their visit to a family planning clinic? 2. What things make it easier or harder to ask about PrEP in a family planning clinic setting? 3. What things make it easier or harder to begin PrEP in a family planning clinic setting? Patient participants: 1. Will receive standardized counseling about PrEP. 2. Will have the opportunity to begin PrEP as part of their routine, ongoing care. 3. Will be asked to complete a survey about their experiences. Physician participants: 1. Will receive standardized education about PrEP. 2. Will talk to patient participants about PrEP, and support patient participants who want to begin PrEP. 3. Will be asked to complete pre-and post-study surveys about their experiences. 4. May be asked to complete a post-study in-depth interview about their experiences.
Eligibility Criteria
This study will include patient participants who: * Are age 16 or older * Are presenting for care at the Women and Infants Hospital of Rhode Island Family Planning Clinic * Speak English or Spanish * Have decisional capacity This study will exclude patient participants who: \- Are currently seeking abortion care This study will include physician participants who: \- Provide care at the Women and Infants Hospital of Rhode Island Family Planning Clinic This study will not have any specific exclusion criteria for physician participants.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06930508 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, studying HIV. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06930508 currently recruiting?
Yes, NCT06930508 is actively recruiting participants. Contact the research team at benjamin_brown@brown.edu for enrollment information.
Where is the NCT06930508 trial being conducted?
This trial is being conducted at Providence, United States.
Who is sponsoring the NCT06930508 clinical trial?
NCT06930508 is sponsored by Women and Infants Hospital of Rhode Island. The trial plans to enroll 83 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.